BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18156933)

  • 1. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients.
    Viale G; Dell'Orto P; Biasi MO; Stufano V; De Brito Lima LN; Paganelli G; Maisonneuve P; Vargo JM; Green G; Cao W; Swijter A; Mazzarol G
    Ann Surg; 2008 Jan; 247(1):136-42. PubMed ID: 18156933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study.
    Mansel RE; Goyal A; Douglas-Jones A; Woods V; Goyal S; Monypenny I; Sweetland H; Newcombe RG; Jasani B
    Breast Cancer Res Treat; 2009 Jun; 115(3):595-600. PubMed ID: 18716862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A validation study of a new molecular diagnostic assay: the Dartmouth-Hitchcock Medical Center experience with the GeneSearch BLN assay in breast sentinel lymph nodes.
    Tafe LJ; Schwab MC; Lefferts JA; Wells WA; Tsongalis GJ
    Exp Mol Pathol; 2010 Feb; 88(1):1-6. PubMed ID: 19840784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes.
    Martin Martinez MD; Veys I; Majjaj S; Lespagnard L; Schobbens JC; Rouas G; Filippov V; Noterman D; Hertens D; Feoli F; Bourgeois P; Durbecq V; Larsimont D; Nogaret JM
    Eur J Surg Oncol; 2009 Apr; 35(4):387-92. PubMed ID: 18639429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the histological size of the sentinel lymph node metastases using RT-PCR assay: a rapid tool to estimate the risk of non-sentinel lymph node invasion in patients with breast cancer.
    Veys I; Majjaj S; Salgado R; Noterman D; Schobbens JC; Manouach F; Bourgeois P; Nogaret JM; Larsimont D; Durbecq V
    Breast Cancer Res Treat; 2010 Dec; 124(3):599-605. PubMed ID: 19779817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eighteen months clinical experience with the GeneSearch breast lymph node assay.
    Veys I; Durbecq V; Majjaj S; Schobbens JC; Noterman D; Sirtaine N; Martinez MD; Hertens D; Feoli F; Bourgeois P; Nogaret JM; Larsimont D
    Am J Surg; 2009 Aug; 198(2):203-9. PubMed ID: 19249740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
    Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
    Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the GeneSearch breast lymph node assay for the rapid evaluation of sentinel lymph nodes in breast cancer.
    Funasako Y; Uenosono Y; Hirata M; Arigami T; Yanagita S; Arima H; Ehi K; Kijima Y; Yoshinaka H; Natsugoe S
    Cancer; 2010 Oct; 116(19):4450-5. PubMed ID: 20572048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA.
    Dell'Orto P; Biasi MO; Del Curto B; Zurrida S; Galimberti V; Viale G
    Breast Cancer Res Treat; 2006 Jul; 98(2):185-90. PubMed ID: 16538532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay.
    Tamaki Y; Akiyama F; Iwase T; Kaneko T; Tsuda H; Sato K; Ueda S; Mano M; Masuda N; Takeda M; Tsujimoto M; Yoshidome K; Inaji H; Nakajima H; Komoike Y; Kataoka TR; Nakamura S; Suzuki K; Tsugawa K; Wakasa K; Okino T; Kato Y; Noguchi S; Matsuura N
    Clin Cancer Res; 2009 Apr; 15(8):2879-84. PubMed ID: 19351770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection of breast cancer metastasis in sentinel lymph nodes by reverse transcriptase polymerase chain reaction (RT-PCR): identifying, evaluating and establishing multi-marker panels.
    Wallwiener CW; Wallwiener M; Kurth RR; Röhm C; Neubauer H; Banys MJ; Staebler A; Schönfisch B; Meuer SC; Giese T; Fehm TN
    Breast Cancer Res Treat; 2011 Dec; 130(3):833-44. PubMed ID: 21858660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.
    Nissan A; Jager D; Roystacher M; Prus D; Peretz T; Eisenberg I; Freund HR; Scanlan M; Ritter G; Old LJ; Mitrani-Rosenbaum S
    Br J Cancer; 2006 Mar; 94(5):681-5. PubMed ID: 16495929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intra-operative GeneSearch(TM) BLN assay for detecting breast cancer metastases in sentinel lymph nodes].
    Wang YS; Liu YH; Ouyang T; Yang XH; Wu J; Su FX; Sun X; Liao N; Zhong WX; Yang WT
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(2):81-5. PubMed ID: 21418987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes.
    Ouellette RJ; Richard D; Maïcas E
    Am J Clin Pathol; 2004 May; 121(5):637-43. PubMed ID: 15151203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative cytologic examination of breast sentinel lymph nodes: test utility and patient impact.
    Dabbs DJ; Fung M; Johnson R
    Breast J; 2004; 10(3):190-4. PubMed ID: 15125743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
    Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
    J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular assessment of sentinel lymph node in breast cancer management.
    Douglas-Jones AG; Woods V
    Histopathology; 2009 Jul; 55(1):107-13. PubMed ID: 19469912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription-reverse transcription concerted reaction and minimal residual disease in axillary sentinel nodes of breast cancer.
    Ishikawa T; Miyajima E; Sasaki T; Tanabe M; Matsumoto C; Nozawa A; Kawachi K; Fukuno Y; Takeda H; Hayashi T; Onaka S; Momiyama N; Ichikawa Y; Inui K; Shimada H
    Eur J Surg Oncol; 2007 May; 33(4):430-4. PubMed ID: 17101257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of intraoperative molecular assay in sentinel lymph node biopsy from breast cancer patients].
    Li DL; Yang WT; Cai X; Xu XL; Xu WP; Chen JJ; Yang BL; Wu J; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):729-33. PubMed ID: 21215161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of three mRNA markers for the detection of lymph node metastases.
    Berger J; Mueller-Holzner E; Fiegl H; Marth C; Daxenbichler G
    Anticancer Res; 2006; 26(5B):3855-60. PubMed ID: 17094413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.